Mefenal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mefenal

Property Description
Active Ingredient Mefenamic Acid
Common Forms Tablet, Capsule, Oral Suspension
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief of pain, inflammation, and fever
Origin Synthetic compound

What is Mefenal and its Pharmacological Class?

Mefenal is a specific brand name for a medication containing Mefenamic Acid, a synthetic compound definitively categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This classification sets it apart from opioid analgesics, as Mefenamic Acid is a non-narcotic agent operating peripherally. Its therapeutic utility is clinically recognized for its established ability to exhibit analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) activities. Pharmacological studies confirm that Mefenamic Acid belongs to the Fenamate group of chemicals, which are anthranilic acid derivatives.


Composition, Forms, and General Therapeutic Purpose

The Mefenamic Acid within Mefenal is a single active ingredient product, which simplifies its overall action. Mefenal is typically positioned in the market as a prescription-only medicine (Rx), focused on patient groups that require robust relief from acute symptoms. It is formulated for oral administration and commonly supplied in solid dosage forms such as a tablet or capsule. The overall therapeutic purpose of this NSAID is to provide symptomatic relief by lessening physical discomfort and physiological responses. The general efficacy of Mefenamic Acid for pain relief is supported by extensive clinical literature. This evidence supports the general conclusion that Mefenal effectively helps patients manage their experience of pain, inflammation, and fever.

What side effects are possible with Mefenal?

Possible Side Effects and Safety Information

Mefenamic acid (Mefenal), as an NSAID, carries a Boxed Warning regarding two serious, potentially fatal risks: Cardiovascular Thrombotic Events (including myocardial infarction and stroke) and serious Gastrointestinal (GI) Adverse Events (including bleeding, ulceration, and perforation).

Serious and Clinically Significant Risks

The risks of serious cardiovascular and GI events may increase with the duration of use and higher doses. Due to these risks, mefenamic acid is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Additional severe adverse reactions reported include Serious Skin Reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), acute Renal Failure (sometimes leading to interstitial nephritis or papillary necrosis), and severe Hypersensitivity Reactions (Anaphylaxis).

Common Adverse Reactions

The most common adverse reactions involve the gastrointestinal system. These typically include diarrhea, abdominal pain, and nausea with or without vomiting. Other commonly reported effects include dizziness, headache, and tinnitus (ringing in the ears).

Safety Restrictions and Contraindications

Use is restricted in several populations. It is contraindicated in patients with a history of allergic-type reactions (asthma, urticaria) to aspirin or other NSAIDs, active GI ulceration or chronic inflammation (e.g., inflammatory bowel disease), severe renal or hepatic failure, and during the last three months of pregnancy. Caution is required in patients with pre-existing cardiovascular conditions, hypertension, or fluid retention.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Mefenamic acid (Mefenal) requires immediate medical attention. The symptoms following an acute overdose are typically categorized by severity and the physiological systems affected.

Documented Overdose Symptoms

Symptoms following acute overdose of NSAIDs like Mefenamic acid are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain. Gastrointestinal bleeding may also occur. A characteristic and potentially severe symptom of Mefenamic acid overdosage is the occurrence of convulsions (seizures), which may be preceded by agitation and twitching. More severe, but less common, presentations include acute kidney failure, hypertension, respiratory depression, and coma.

When to Seek Immediate Medical Help

It is crucial to immediately call emergency services (such as 911 or the local emergency number) if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

In any case of suspected overdose, contact a poison control center immediately for guidance. Management of Mefenamic acid overdose is primarily symptomatic and supportive, as there is no specific antidote. Treatment may involve decontamination procedures such as the administration of activated charcoal.

Therapeutic Uses of Mefenal

What Mefenal Treats: Main Uses and Benefits

Mefenal (Mefenamic Acid) is commonly used to help with symptoms related to physical discomfort, inflammatory, and irritative states. The medication is used in areas where short-term symptom management is appropriate, particularly relevant in conditions characterized by periods of heightened symptoms, such as dysmenorrhea. It is often applied in contexts where symptoms create noticeable interference with daily stability, requiring short-term supportive assistance.


Symptom Management and Therapeutic Support

The medication is commonly used to help with symptoms related to heightened physiological activity, such as the cramping associated with primary dysmenorrhea, and is relevant for managing symptoms linked to organ-specific functional stress, such as heavy menstrual blood loss (menorrhagia). Additionally, Mefenal is generally used across conditions presenting with acute episodes characterized by mild to moderate pain intensity, including pain following dental procedures or minor surgical interventions. It may also be part of symptomatic management for inflammation symptoms like swelling and tenderness during acute exacerbations of conditions involving inflammatory processes, and is used to help with symptoms related to systemic imbalance, such as elevated body temperature (fever).

This supports patients during episodes of heightened discomfort and may assist with maintaining functional stability.

Quick Fact: Symptom Management for Menstrual Cramps

Eligibility and Restrictions for Use

Mefenal (mefenamic acid) is a Nonsteroidal Anti-inflammatory Drug (NSAID) primarily used to treat mild to moderate acute pain and primary dysmenorrhea (menstrual cramps) in adults and adolescents, generally for short periods (no more than 7 days for pain). It is typically approved for use in individuals 14 years of age and older.


Contraindications (Who Should Not Use Mefenal)

Because of the risk of serious side effects, Mefenal should not be used in patients with certain pre-existing conditions. Absolute contraindications include:

  • A history of asthma, hives (urticaria), or other allergic-type reactions to aspirin or other NSAIDs.
  • Active gastrointestinal issues, such as an active ulcer or chronic inflammation in the stomach or intestines.
  • Severe kidney or liver failure.
  • Severe heart failure or treatment of peri-operative pain after a Coronary Artery Bypass Graft (CABG) surgery.
  • Late stages of pregnancy (starting at about 20 weeks), due to potential harm to the fetus.

Use in Specific Populations

  • Children: Safety and efficacy have not been well-established for children under 14 years old.
  • Elderly: Older adults may be at increased risk for serious gastrointestinal or renal side effects. The lowest effective dose should be used for the shortest duration.

What should I know about interactions with other medicines?

Mefenal (mefenamic acid) is an NSAID and should be used cautiously with many other medications, as interactions can alter the effectiveness of Mefenal or the other drug, or increase the risk of side effects, particularly bleeding or kidney damage.


Medications to Discuss with Your Doctor

It is crucial to inform your healthcare provider of all prescription and non-prescription medicines, vitamins, and herbal products you are taking. Significant interactions include:

  • Other NSAIDs (e.g., ibuprofen, naproxen, aspirin): Concomitant use greatly increases the risk of serious gastrointestinal issues, such as bleeding and ulcers.
  • Anticoagulants (e.g., warfarin) and Antiplatelets (e.g., low-dose aspirin): Increased risk of severe bleeding.
  • Diuretics ("water pills") and Blood Pressure Medications (e.g., ACE inhibitors, ARBs): Mefenal can reduce the effectiveness of these drugs and may increase the risk of kidney problems.
  • Lithium and Methotrexate: Mefenal may increase the levels of these drugs in the blood, leading to potential toxicity.
  • Corticosteroids (e.g., prednisone): Increased risk of gastrointestinal bleeding or ulceration.
  • Selective Serotonin Reuptake Inhibitors (SSRIs): May increase the risk of gastrointestinal bleeding.
  • Magnesium-containing antacids (e.g., Milk of Magnesia): These can increase the absorption and blood levels of mefenamic acid, potentially increasing side effects.

It is generally recommended to avoid alcohol while taking Mefenal, as it may further increase the risk of stomach irritation and bleeding.

Mechanism of Action

Targeted Inhibition of Prostaglandin Synthesis

Mefenamic Acid functions as a non-selective inhibitor of the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). This molecular block prevents the conversion of Arachidonic Acid into Prostaglandins (PGs), which are chemical messengers that sensitize pain receptors and mediate local vascular changes.


️ Modulation of Nociceptive and Central Thermoregulatory Pathways

The reduction in PGE2 synthesis leads to a significant downstream effect: it dampens the activation of peripheral nerve endings (nociceptors), modulating the excitability of peripheral nerve endings. Centrally, the same PGE2 reduction in the hypothalamus alters the hypothalamic thermoregulatory set point, which engages mechanisms for heat dissipation.


Distinct Action on Uterine Smooth Muscle Function

Beyond its general COX inhibition, Mefenamic Acid possesses a distinct mechanism that involves directly modulating the responsiveness and contractility of uterine smooth muscle tissue. This targeted effect on muscle tone modulates the physiological contractility of uterine smooth muscle tissue, distinct from the COX inhibition cascade.

Dosage and Administration Information

Official Administration Guidelines for Mefenal

Mefenamic Acid (Mefenal) is an oral medication that must be used strictly according to the administration rules provided in regulatory labeling. These guidelines define the correct initial dose, frequency, and maximum duration of use.


Standard Dosing Schedule

Administration Scope Official Instruction (Adults 14 years)
Route of Administration Oral (PO)
Initial Dose 500 mg once
Maintenance Dose 250 mg
Frequency Every 6 hours as needed (PRN)
Maximum Duration (Acute Pain) Usually not to exceed 7 days
Maximum Duration (Primary Dysmenorrhea) Usually not to exceed 2 to 3 days

Administration Conditions

To minimize gastrointestinal irritation, the capsules or tablets should be taken with food or milk. For primary dysmenorrhea (menstrual pain), treatment should be initiated at the onset of both bleeding and associated symptoms.

Age and Missed Dose Rules

Use in pediatric patients under 14 years of age has not been established and is generally not recommended. For geriatric patients, caution is advised due to the increased likelihood of age-related kidney issues, which may necessitate careful dosage management. If a dose is missed, skip the forgotten dose and resume the regular dosing schedule; do not take a double dose to compensate. The lowest effective dose for the shortest duration consistent with treatment goals must be used.

Recent Clinical Evidence

Research Evidence / Overview of studies for Mefenal


Evidence for use in Type 2 Diabetes Mellitus

Research has explored Mefenal in adults with Type 2 Diabetes Mellitus (T2DM). The studies used to evaluate this focused mainly on Randomized Controlled Trials (RCTs), which are designed to compare the agent against a placebo or another active treatment over defined time intervals. These studies monitored outcomes related to systemic or functional imbalance, such as changes in the long-term measure of blood sugar called HbA1c, as well as changes in fasting glucose levels and body weight.

Studies reported measurements of blood sugar markers that were observed to be different in groups receiving Mefenal over the short-term and intermediate-term observation periods compared to control groups. Research highlights the measurement of HbA1c and body weight during the study period. Patient-reported outcomes describing perceived discomfort or the frequency of low blood sugar events (hypoglycemia) were also evaluated.

Evidence for use in Cardiovascular Risk Reduction

Research examined Mefenal in the context of cardiovascular outcomes, which involved large-scale, dedicated Cardiovascular Outcomes Trials (CVOTs). These long-term studies monitored physiological strain or stress in adults with T2DM who also had established heart disease or multiple cardiovascular risk factors. The primary goal was to observe the patterns related to the occurrence of major heart and circulation issues (MACE), such as non-fatal heart attack, non-fatal stroke, and death from cardiovascular causes.

Data describe patterns related to the incidence of these major cardiovascular events. Studies monitored the frequency of these events in the populations studied. Findings were reported across both primary and secondary prevention cohorts examined within the large-scale trials. Research is ongoing to fully understand the factors associated with the reported cardiovascular patterns.


What is Still Uncertain About Mefenal

Information regarding many outcomes over a very long-term period is not fully established, as follow-up durations were limited across many trials. Data for certain groups, particularly pediatric populations, pregnant individuals, and those with severe, complex comorbidities, remain insufficient. Comparative evidence is lacking to fully contextualize all the observed patterns, and research is ongoing to address these limitations. Results apply only to the specific populations studied, and findings were mixed in some smaller analyses.

Key Studies & References

  1. NICE Guideline NG28: Type 2 diabetes in adults: management (Representative Clinical Guideline)

Frequently Asked Questions (FAQ)

Common questions about Mefenal (FAQ)

Q: How quickly can I expect Mefenal to start working?

Official information and administration guidelines indicate that Mefenal is typically used on an as-needed basis. The recommended dosing frequency is every six hours, and this schedule is based on the drug's expected duration of action. While individual response times may vary, the established dosing interval helps guide patient expectations.


Q: How long does the effect of Mefenal usually last?

The manufacturer’s dosing instructions for Mefenal generally recommend administration every six hours. This four-time-a-day schedule aligns with the drug's established duration of effect, based on how the active ingredient is processed by the body according to pharmacological studies.


Q: What are the signs that Mefenal is not working for me?

Mefenal is approved for the short-term, symptomatic relief of specific types of mild to moderate pain. If the intended relief is not achieved, or if symptoms appear to worsen during the maximum recommended treatment duration, this may indicate a lack of therapeutic response. Official product documents focus on the drug's intended action and do not specifically outline a timeframe for lack of response.


Q: Can Mefenal cause drowsiness?

Yes, official drug labels and patient safety information list drowsiness as a possible central nervous system side effect of Mefenamic Acid. Other commonly reported effects include dizziness and headache. Users experiencing these effects are advised to be mindful of how they feel.


Q: Does taking Mefenal affect driving or operating machinery?

Because Mefenal can cause side effects like dizziness and drowsiness in some users, official documents advise caution. Users are advised to assess how the medication affects them before engaging in activities that require full attention, like driving or operating machinery.


Q: What is the difference in how Mefenal and opioids work?

Mefenal is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID) that functions by targeting and inhibiting local chemical messengers in the body called prostaglandins. It is designated as a non-narcotic agent and acts differently from opioid analgesics, which primarily affect the central nervous system.


Q: Is Mefenal the same as other medicines for pain relief?

No, Mefenal is a specific brand name for the active ingredient Mefenamic Acid, which is definitively categorized in the NSAID (Fenamate) class of medicines. This classification distinguishes it from other general types of pain relievers, such as acetaminophen.


Q: Is Mefenal a controlled substance?

Mefenal (Mefenamic Acid) is a non-narcotic NSAID. According to regulatory sources, it is not listed as a controlled substance under the U.S. Controlled Substances Act. Due to its non-narcotic classification, Mefenal is not categorized with drugs that have been scheduled due to their potential for abuse or dependency.


Q: What types of foods should be avoided while taking Mefenal?

Official information advises taking Mefenal with food or milk to help reduce the potential for stomach irritation. Specific food restrictions are not detailed, however, regulatory information suggests caution regarding co-administration with products containing magnesium, such as certain antacids, as this can increase the absorption of Mefenal.


Q: Are there any long-term risks associated with Mefenal use?

The official Boxed Warning states that the risk of serious side effects, including cardiovascular events (like heart attack and stroke) and severe gastrointestinal events (like bleeding and ulceration), may increase with the duration of use. Official regulatory documents indicate that the medication is approved for short-term use, and this risk is associated with the duration of use.


Q: Does Mefenal interact with common supplements like multivitamins?

Official drug information advises patients to inform their healthcare provider of all prescription, non-prescription, vitamin, and herbal products they are taking. This general precaution is necessary because many common supplements may contain ingredients that could affect the risk of bleeding or alter how Mefenal is processed by the body.


Q: Can Mefenal affect my sleep?

Official safety data lists certain central nervous system effects as possible adverse reactions. Specifically, insomnia (difficulty sleeping) and dream abnormalities are reported as psychiatric or nervous system side effects of Mefenamic Acid.


Q: Can Mefenal be used for headaches or migraines?

Mefenal is formally indicated for the relief of mild to moderate acute pain and primary dysmenorrhea (menstrual cramps). The approved indications provided in the official regulatory documents do not specifically list the treatment of migraines.


Q: Why do official documents mention heart risk with Mefenal?

Official drug documents include a Boxed Warning to communicate that Mefenal, like other NSAIDs, may cause an increased risk of serious and potentially fatal cardiovascular events, such as heart attack and stroke. This caution is based on data that shows this risk can occur early in treatment and may increase with the length of use.


Q: Is Mefenal a generic medicine?

Mefenal is a specific brand name containing the active ingredient Mefenamic Acid. According to drug regulatory databases, Mefenamic Acid is also available from several manufacturers as a therapeutically equivalent generic product.


Q: Can Mefenal make me sensitive to the sun?

Yes, regulatory labeling and patient safety resources mention an increased sensitivity of the skin to sunlight, known as photosensitivity, as a possible adverse reaction. Given the risk of photosensitivity, regulatory resources indicate the need for caution regarding sun exposure while using this medication.


Q: Does Mefenal affect birth control pills?

Official drug interaction information notes that Mefenal has the potential to interact with certain types of oral contraceptives. This potential interaction, such as with pills containing drospirenone, may affect blood potassium levels, and other interactions are also possible. Comprehensive interaction lists should be discussed with a healthcare provider.


Q: Can Mefenal affect the liver?

Mefenal is associated with the potential for effects on the liver, including elevations in liver function tests. Official documents indicate that severe hepatic failure is a contraindication. Furthermore, if signs of liver problems, such as unusual fatigue or yellowing of the skin, develop, the medication should be discontinued and medical attention should be sought.

How should Mefenal be stored and disposed of?

How to Store and Dispose of Mefenal?

Regulatory documentation defines strict environmental and handling requirements to maintain the stability and safety of Mefenal (Mefenamic Acid).

Official Storage Requirements

  • Temperature: Store at controlled room temperature, which must not exceed 30 C.
  • Protection: Keep the medication in its original, tightly closed container and protect it from freezing, excess heat, moisture, and direct light.
  • Child Safety: It is mandatory to store Mefenal out of the sight and reach of children.

Official Disposal Guidelines

  • Unused/Expired Product: Do not keep outdated medicine. Consult government guidance or a pharmacist for disposal.
  • Environmental Rule: Mefenal must not be flushed down the toilet. The safest option is using a drug take-back program. If unavailable, unused product should be mixed with an undesirable substance (e.g., dirt or coffee grounds) and sealed before disposal in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mefenal found in:

A-Z Index: